Localization of the T-cell response to RSV infection is altered in infant mice

Katherine M Eichinger1,2, Jessica L Kosanovich1, Kerry M Empey1,2,3,4

  • 1Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania.

Pediatric Pulmonology
|November 9, 2017
PubMed

Insights

Infant mice infected with respiratory syncytial virus (RSV) show T-cell deficiencies in the airways. Early intranasal interferon-gamma (IFN-γ) boosts RSV-specific CD8+ T-cells in infant lungs, suggesting a potential therapeutic avenue.

Area of Science:

  • Immunology
  • Virology
  • Pediatrics

Background:

  • Respiratory syncytial virus (RSV) is a major cause of severe respiratory illness in infants.
  • Infant T-cell responses in the airways during RSV infection are not well understood.
  • Stronger Th1 responses correlate with less severe RSV disease in infants.

Purpose of the Study:

  • To compare T-cell localization in the airways of infant and adult mice infected with RSV.
  • To investigate the impact of local interferon-gamma (IFN-γ) administration on infant T-cell immunity during RSV infection.
  • To test the hypothesis of quantitative and qualitative T-cell deficiencies in RSV-infected infant airways.

Main Methods:

  • Comparison of T-cell populations (CD4+, CD8+) in bronchoalveolar lavage fluid of infant and adult RSV-infected mice.
  • Assessment of T-cell localization (lung tissue vs. airway) and T-bet expression.
  • Administration of local IFN-γ to infant airways and intranasal IFN-γ to assess effects on T-cell responses.

Main Results:

  • Adult mice showed accumulation of CD8+ and CD4+ Tbet+ T-cells in alveolar spaces; infants had even distribution of CD4+ Tbet+ T-cells.
  • Infant lungs had higher frequencies of CD8+ T-cells compared to adults.
  • Local IFN-γ administration did not increase airspace T-cells and reduced CD4+ Tbet+ T-cells, but intranasal IFN-γ increased RSV F protein-specific CD8+ T-cells in the alveolar space.

Conclusions:

  • Infant T-cell responses to RSV exhibit quantitative and qualitative defects.
  • Early, local administration of IFN-γ can enhance the RSV-specific CD8+ T-cell response in the infant airway.
  • These findings highlight potential therapeutic strategies targeting infant T-cell immunity against RSV.
Abstract